Halaven (eribulin mesylate) | Injection Chemotherapy for Metastatic Breast Cancer
Clic: 101, sito web aggiunto: Jun 11, 2015
|
|
| |||||||
Halaven (eribulin mesylate) monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease.